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ABSTRACT
Chewing gum is a highly convenient and controlled release transbuccal drug delivery system taken without water. It is gaining popularity as a self-
administrable carrier for the medication used for motion sickness, smoke cessation, hypertension, xerostomia, dental caries, pain, as nutritive and 
energy supplements. Functional chewing gum favors both local and systemic effects intended to be chewed about half an hour. It has emerged out with 
a fast onset of action either by direct absorption or swallowed with saliva into gastrointestinal tract. It has better bioavailability that lowers the doses 
and reduces the gastric side-effects. Gums adhere with ease and compliance of administration to children and dysphagia patients. Chewing gums 
are formulated using a water-insoluble gum base with water-soluble excipients with the active ingredient in the case of medicated gums. European 
Pharmacopeia standards used for release studies, there are no other particular official standards. It has attracted the researchers as successful 
potential drug delivery system in coming future. The present article reviews it as novel drug delivery system including its merits and limitations, 
material and methods of formulation and evaluation.
Keywords: Chewing gum, Transbuccal, Systemic effects, Self-administrable, Gum bases, Novel drug delivery system.
INTRODUCTION
Chewing gum has been used by mankind since ancient times primarily 
for pleasure. Old dynasty of Mayan Indians chewed tree resins for the 
aim to keep their breath and teeth hygiene. In old times, it is a well-
known fact that chewing gums increase mental performance, verbal 
and cognitive skills. After the patent in 1869 on chewing gum America 
has launched Aspergum, a medicated analgesic chewing gum [1,2]. 
Today, chewing gum is highly accepted as a drug delivery system either 
for pharmaceutical or nutraceuticals. It has specially recommended in 
smoking cessation and motion sickness. Gums are the only among all 
type of delivery systems that can be ingested without the need of water 
or any skilled person anywhere. In addition, medicated chewing gums 
are so much useful in the treatment of oral cancer, hypertension, and 
cardiovascular diseases (CVS) [3,4]. Disadvantage of the buccal route 
of administration is the inability to maintain the dosage form for a long 
period that gives birth to the area of the mucoadhesive dosage form 
for transbuccal drug administration such as chewing gums. Owing 
to new social and behavioral trends in the past modern age, such as 
the growing consumer health awareness and increasing attention to 
safety products, chewing gum has been known for a new image and 
potential [5]. Chewing gum today is gaining consideration as a vehicle 
or a delivery system to administer active principles even for over the 
counter medicines to improve health and nutrition. Chewing gums 
usually contains insoluble gums and resins as a core material with 
water-soluble excipients such as humectants, sweeteners, softeners, 
and flavoring agents with active ingredients. The review found it as 
a better targeted and controlled release dosage form for an extended 
period in the local or systemic region [6].
Oral cavity
In the aim of mucosal or oral drug delivery necessary to know the 
morphology of mucosa. It is a thin layer of stratified epithelium 
covered with mucus and saliva. The mucosa constitutes a resilient 
barrier to active substances as well as other substances. It has 
20-40 layers of cells with a thickness of 450-600 µm with a perfusion 
rate of 20-40 ml/minutes/100 cm2 [7]. Submucosa is highly vascular 
and rapidly removes any permeated active substance to the systemic 
circulation thus avoiding the first-pass metabolism. A drug can be 
administered via oral or peroral route for both the systemic and local 
effect. There are two principal sites of absorption sublingual and buccal 
region where the medicine consisting of mucoadhesive polymers used 
for topical and semi-topical purpose as shown in Fig. 1 [8,9].
BUCCAL ADMINISTRATION OF DRUGS
In view of the potential of bypassing, the hepatic first pass metabolism 
associated with oral administration systemic delivery through skin and 
mucosa has received attention. Mucosal surfaces at different positions in 
the body serve as a site of absorption for the drug. Buccal mucosa for drug 
delivery has excellent accessibility (easy to attach and detach dosage 
form) with high patience compliance due to painless administration [10]. 
Robustness of mucosa with a variety of dosage forms makes it an ideal site 
for absorption of various drugs, especially which extensively metabolized 
in the liver and required immediate action like cardioselective and 
antihypertensive drugs [11]. Mucosa is more permeable and perused 
than the skin but lesser than sublingual membrane because the sublingual 
membrane is thinner and usually immersed in saliva. Absorption in oral 
cavity takes place via different phenomena such as simple diffusion 
(concentration gradient flow), facilitated diffusion (carrier or ion 
mediated flow), intercellular movements based on molecular weight of 
substances, and endocytosis [12,13].
Rational of transbuccal route
From the viewpoint of drug administration oral mucosa offers various 
advantages:
•	 By	passing	the	liver	with	the	help	of	reticulated	vein	beneath	the	
mucosa prevents the reduction in the potency or amount.
•	 Excluding	destructive	acids	of	the	gastric	region	and	metabolizing	
enzymes of intestine.
•	 The	better-suited	 route	 for	 the	drugs	having	poor	absorption	 in	
gastric region.
•	 Therapeutic	concentration	can	be	achieved	more	rapidly	because	of	
no interference due to gastric contents or disease.
•	 Very	first	choice	of	administration	for	unconscious	patients.
•	 It	also	allows	the	opportunity	to	locally	modify	tissue	permeability	
inhibit protease activation to reduce immunogenic response. 
Therefore, selectivity for therapeutic agents can be achieved.
© 2017 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2017.v10i6.18307
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•	 A	passive	system	so	does	not	require	any	activation	[14,15].
•	 The	degree	of	perfusion	(blood	circulation)	is	very	high	in	comparison	
of skin [11] and sublingual tissues [16].
•	 Saliva	has	 a	 large	 amount	 of	water	 in	 it	 that	 is	 better	 for	drug	
dissolution, unlike rectal and transdermal route.
Limitations of transbuccal route
•	 This	route	is	suited	only	for	those	drugs	which	absorbed	by	passive	
diffusion.
•	 Unpalatable and noxious drugs which irritate the mucosa not suitable 
for this route.
•	 A	small	dose	can	be	administered	because	of	the	lesser	surface	area	
(200 cm2) of absorption.
•	 Drug	swept	off	with	the	swallowed	saliva	does	not	follow	advantages	
of the buccal route.
•	 Ingestion	of	any	other	substance	parallel	may	become	restricted.	It	




integrity of the formulation may get disrupted.
•	 A	major	 disadvantage	 of	 buccal	 delivery	 of	 the	 drug	 is	 the	
maintenance of the dosage form at the site for an extended period 
in a particular region of the body. Recent approaches to this cadre 
are the use of buccal or mucosal adhesive polymers having better 
drug release [18].
CHEWING GUM AS A DRUG DELIVERY SYSTEM
This unique dosage form utilizes the adhesive properties of some water-
soluble polymers which can be applied on a wet surface or tissues or 
the mucosa. Such polymers which have been identified as hydrophilic 
macromolecules containing numerous hydrogen bond forming groups 
become adhesive on hydration and are therefore called wet adhesive, 
bioadhesive, therefore maintains the pharmaceutical dosage form for a 
clearly defined time at its activity or resorption level [19].
Advantage of chewing gums
There are many reasons for choosing chewing gum as a drug delivery 
system over conventional routes, some of which are described below.
Efficacy
It has a very good local effect due to having a long time of chewing and 
sustaining is there so used in the treatment of diseases in cavity and 
throat. Low doses are suitable because chewing gums can bypass the 
hepatic first pass metabolism. Xerostomia or dry mouth is often seen 
in the case of antidepressants and Sjogren’s syndrome, but chewing 
gum stimulates salivary secretion so beneficial to dental health [20]. 
Drug can directly absorb through the buccal mucosa for systemic effect 
and fast onset of action because drug passed by jugular veins like 
Dextromethorphan hydrobromide in Pharmagum-M [21,22].
Convenience and compliance
Easy to store and less prone to microbial contamination. It is highly 
acceptable in children and patient with nausea and dysphagia. It is 
palatable, pleasant and attractive for the lower age. This is the only 
dosage firm conveniently taken anywhere anytime without any water 
intake that makes it 21st century drug delivery system which avails self-
administration in current lifestyle [23].
Gastric friendly
Gums do not get direct exposure to the gastrointestinal mucosa, so this 
reduces the side effects of excipients and risk of intolerance of gastric 
mucosa. Chewing or mastication normally acts as salivary gouge and 
buffering capacity of saliva reduces the acidity of gastric fluids. The 
fraction of drug reaching the stomach continuously with the saliva, so 
the duration of action is increased [24,25].
Limitations of chewing gums
•	 Sorbitol	and	mannitol	present	 in	chewing	gums	 formulation	may	
cause	flatulence	and	diarrhea	[20].
•	 Adherence	problem	of	gums	to	different	degrees	to	enamel	dentures	
and	 fillers.	 Involuntary	swallowing	sweep	off	 the	active	principle	
released into saliva from the site of action [26].




COMPOSITION OF CHEWING GUM
Chewing gum usually consists of water-insoluble and water-soluble 
portions in appropriate ratio as depicted (Figs. 2 and 3). Active core 
material usually mixed with the insoluble base material. In the 
formulation, there are no added preservatives due to low water 
content [28-33].
MANUFACTURING AND METHODS (FIG. 4)
Formulation of medicated or non-medicated chewing gums has 




to produce damp mass. This mass or dough is passed through series 
of high-pressure rollers to convert it into the ribbon-like structure.
•	 Cutting,	 threading,	and	wrapping	 take	place	as	per	required	size.	
Chewing gum formulation contains the following components as 
discussed above along with active pharmaceutical ingredients 
(API) in case of medicated chewing gums. In medicated chewing 
gums API can be added into base material or coating or into both. 
The	proportion	should	lie	in	the	range	of	0.5-30%	of	final	weight.	
Coatings can be applied as same as in the case of tablets [33-36].
SOURCES OF EDIBLE GUM BASES
Many of plants are huge sources of edible gums that can be used as 
core material for the formulation. Plants produce latex, resins, gummy 
secretions, and juices as secondary metabolites which are the mainly 
used for this purpose. Plant parts useful for the procuring of the gums 
are trunks roots and barks which also fulfills some other medicinal 
purpose for formulations. Selection of a useful source of gums depends 
on its availability, pharmacological effects, and texture.
CHEWING GUM BASES
From the old times, natural gums are used; the most popular base is 
“Chicle.” Other than this other synthetic gum bases are also getting 
popularity nowadays.
Fig. 1: Cross section of human buccal mucosa
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Fig. 2: Different water-insoluble additives in chewing gums
Fig. 3: Different water-soluble additives in chewing gums
Natural chicle base
It is a type of latex obtained from the Sapodilla tree by making an 
incision on the trunk. These incisions followed by the release of gummy 
secretion that is collected, dried and purified with the help of strong 
alkali and then neutralizing. The dried product goes through powdering 
and the resultant product is insoluble, amorphous powder. Chemically, 
it is composed of 55% of yellow resin and remaining polyisoprene. 
Resin consists of Lupeol acetate with a minor amount of amyrina and 
42
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spinasterol acetates. Refined chicle is used for chewing gum base but 
for those which contains only water-insoluble ingredients [37].
Synthetic gum bases
The gum base generally used consists of natural rubbers and mixture 
with synthetic gum. The most popular synthetic gum bases are 
derivatives of butadiene. The gum bases usually adhere to dental 
surfaces. Antiadhesive or anti-sticking agents such as talc and 
tannic acid [38,39]. The polymer can be used along with polyisoprene 
or styrene butadiene copolymer. The use of titanium dioxide along 
with fillers such as calcium carbonate is also reported to produce 
non-sticky gum [40,41]. Non-sticky bubble-gum can also have some 
sort of elastomers or fatty acid with oleaginous plasticizers [42]. 
A	U.S.	Patent	[41]	has	reviewed	online	which	(4387108)	describes	the	
formulation of non-sticky chewing gum with following composition 
(Tables 1 and 2).
 Rosin
Apart from above conventional gum bases trends rise to use rosin 
derivatives. Rosin is obtained from Pine trees. It is an oleoresin, solid 




Rosins are chemically made of two components, carboxylic rosin acids 
and very less of non-acidic material. The acids are divided into two 
categories that are Asiatic and Pindaric acid. Rosin and its derivatives 
show a wide number of applications in pharmaceutical field excluding 
that in transbuccal dosage form formulation. These acids show 
number or reactions such as esterification, oxidation, hydrogenation, 
polymerization, and isomerization. Their esters are very useful also in 
other industries for the purpose of film forming, coating, and varnishing.
Rosin derivatives have different grades as per ISI with certain 
specifications. It is tabulated as shown in Table 3 [41,42,44].
Shellac
It is also known as Lacca or dewaxed orange shellac. Shellac is a refined 
natural resinous product having a small amount of pigment. Shellac 
on hydrolysis produces a lot of aliphatic acids and fewer amounts of 
salicylic acids. The major acids are Aleuntic acid and shellac acid. 
Different marketed grades of shellac are available. The main grades are 
orange and bleached shellac. Shellac can also be obtained commercially 
in pharmaceutical grades in which the appropriate grade of shellac has 
been dissolved in ethanol [45].
Shellac is thin, hard, brittle, transparent, pale lemon, or brownish 
yellow-orange flakes. It smelting point range is 115-120°°C. All types 
of shellac discussed above have an acid value from 71% to 91% 
about [46,47].
PALATABILITY IN CHEWING GUMS AS BETTER BUCCAL 
ACCEPTABILITY
There are several ways to achieve palatability and mask the bitter taste 
of chewing. Some time chewing also shows absurd taste after chewing 
long time that is because of losing the sweet taste. The methods are as 
followed (Fig. 5) [48,49].
Evaluation of chewing gums
There are several parameters that can be used for evaluation but 
not confined anywhere in any monograph about all; European 
Pharmacopeia suggests, i.e., safety parameters, dissolution parameters, 
and assay only. Other than those are also given below.
Organoleptic evaluation
Appearance, color, flavor, and sweetness index are determined by 
simple volunteer acceptance or survey in human trials by Likert 
Table 1: Formulation in U.S. patent




Non-toxic vinyl polymer 16-32
Emulsifier 05-10
Elastomer solvent 2.5-13
Table 2: Formulation of chewing gum as Indian patent [43]
Type of ingredients Percentage range
Isoprene-isobutylene copolymer 6.5
Polyisobutylene 1.4
Polyvinyl acetate (15000) 2.8
Glyceryl esters 6.5
Hydrogenated wood-resin 2.8
Micro crystalline wax 3.0




Table 3: ISI classified Rosin grades
Color grades Light Medium Dark
X, WW, MG, N M, K, H
Softening point 70-75°C 70-75°C 70-75°C
Relatively density 1.05-1.08 1.05 - 1.08 1.05-1.08
Acid value 160 155 155
% Volatile matter (max) 2.0 2.0 2.0
% Ash content 0.05 0.2 0.5
% Insoluble content 0.1 6.0 6.0
%	Unsaponified	matter 6.0 6.0 6.0
Fig. 5: Methods of improvisation of palatability aspect of gums
Fig. 4: Formulation methods for chewing gums
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score on a scale of 5 points. Artificial tongue simulation can be used 
as a taster for palatability also [50]. Another important aspect of 
physical evaluation is the texture profile (TP). It is a sensory analysis 
and evaluation of characteristics such as hardness, tractability, 
cohesiveness, and gumminess in the case of gums using the standards 
of force-time curves. The test consists of compressing the sample 
twice in a reciprocating motion that imitates the action of the jaw and 
analyzing the textural parameters. Compression plates and flat surfaces 
along with standard probe are used for this. The instrument simulates 
buccal chewing process or mimics the mouth’s biting action, therefore 
also known as two bite test [51].
The melting point of gum base
It is determined by any suitable method to know the temperature which 
the base loose out its texture and behave as a liquid.
Excipients evaluation
It is done using Fourier transform infrared spectroscopy (IR) or 
differential scanning calorimetry techniques to find the interactions in 
the dosage form.
Weight/mass variation
It can carry out as per the guidelines in pharmacopeia for solid dosage 
form using 10 randomly selected chewing gums.
Moisture content
It can be determined IR moisture balance method, desiccation or hot 
air oven method.
Uniformity of drug content
About 10 units from each formulation were individually assayed for 
active content by the suitable method given in monographs it is done 
by crushing and dissolving chewing gum in 100 ml of artificial salivary 
fluid. The solution was then filtered, suitably diluted and read by an 
instrument like ultraviolet spectroscopy or liquid chromatographic 
methods [52].
In vitro dissolution study
It has been done as per monograph gave in European Pharmacopoeia 
as discussed below also. The mechanism of drug release and release 
rate kinetics of the drug from the dosage form, the obtained data were 
fixed in the following model of zero order, first order, Higuchi matrix, 
Korsmeyer and Peppas model by analyzing the R values and the best 
fit model [53,54].
In vivo dissolution study
The in vivo release of therapeutic ingredients from gum base during 
mastication can be done by appointing sufficient numbers of subjects as 
and schedule a clinical trial for chew-out studies. Volunteers are asked 
for a dosage form for a certain period and throw out the residual and 
exhausted gum base. It is real-time process, involves saliva stimulation 
pH variations, buccal absorption and some extent of swallowing. 
Minimum four human volunteers can be selected (2 male and 2 female). 
Instruction like mouth rinsing, chewing period already given before trial 
starts. A sampling of drug meanwhile at different intervals predicted 
which can be assayed as per need [45,52].
In vivo assay of residual gum
After the in vivo dissolution by human volunteers, the collected 
exhausted gum base having a very amount of therapeutic content as 
per hypothesis are subjected to this test. The residual gums are cut 
into small pieces, frozen and then ground to a fine powder state. The 
fine powder is introduced in a suitable solvent and assayed by using 
the suitable analytical method. The amount of drug released during 
mastication is calculated by subtracting the amount of residual active 
ingredient present in the gum from the predetermined total therapeutic 
content of dosage form. The major disadvantage of these studies are 
difficult to standardize because of high variability in chewing pattern, 
chewing frequencies, the composition of individual salivary fluid and 
flow rate of saliva are a few limitations of chew-out studies [55].
Stability studies
Accelerated stability studies of any formulation can be carried out 
as per International Conference on Harmonisation (ICH) Q1A (R2). 
Table 5: Classification of apparatus
Apparatus I Apparatus II (official)
Chewing gum apparatus Alternative chewing gum apparatus
Compendial Non compendial
Christrup and moller Wennergan
Fig. 6: Working of dissolution apparatus
Fig. 7: Six chambered apparatus for in vitro dissolution
Table 4: ICH* storage condition for stability testing




Long term 25°C±2: RH*60±5% or
30°C±2: RH 65%±5
12 months
Intermediate 30°C±2: RH 65%±5 06 months
Accelerated 40°C±2: RH 75%±5 06 months
*ICH: International Conference on Harmonization, RH: Relative humidity
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These parameters and data given below can vary as per climatic 
zones of ICH Guidelines just exampled for common stability condition 
in general case of new drug products and drug dosage form. They 
are kept under such condition and followed by evaluation for any 
physical deformities, the extent of deterioration and to ensure that the 
degradation has not exceeded an acceptable level. Storage condition is 
given (Table 4) [56].
DISSOLUTION AND RELEASE STUDIES OF CHEWING DRUG 
DELIVERY SYSTEM
In European standards classify, the chewing as solid dosage form but it 
can be put under semisolid dosage forms. It has described an apparatus 
to study the rate of release. For simulation of buccal mastication 
or chewing system in vitro, a special chewing chamber designed. It 
contains a buffer solution of same pH and temperature as the mouth. 
Chewing rate and the angle of force is controlled from outside of the 
machine. The apparatus are classified as shown in Table 5.
Release profiles for kinetics and release patterns are essential to 
establish for approval of any new drug delivery systems, but in the case 
of chewing gums as transbuccal dosage form, a conventional apparatus 
would not help. There must be some modified apparatus that includes 
masticator actions in it like above.
Logical sequence of release of API is like first while chewing; then, 
reaches the saliva followed by systemic absorption or directed to the 
gut pathway. This study requires human subjects, disability to control 
the variability in chew pattern, chew speed, saliva flow, and saliva 
composition [52]. Simulation of this process is published in European 
Pharmacopoeia.
Official chewing gum dissolution apparatus
Structure and working
It is a single chamber instrument consists of two horizontal pistons (HP) 
working like jaw and a third vertical piston (VP) mimics the tongue. The 
VP moves alternatively with the horizontal one. The HP has some rings 
attached to it, shape as alphabet “O.” Sealing rings of the chamber make 
it water tight. The HP also rotate oppositely in some case to produce the 
highest chewing. Chewing chamber has one funnel shape part and two 
guides which control the movement of HP. The distance between the HP 
is 50 mm, and the minimum is 0. To 1 mm whereas for VP the impact and 
rest position has a distance of 22 mm. The temperature of the chamber 
can be maintained at 37±0.5°C. The variables in hand are chewing rate 
(up to 60 strokes/minutes), volume if dissolution medium inter-jaw 
distance and the rate of twisting movement. Chewing chamber capacity 
is 40 ml but prefers up to half of it with saliva simulation of ph about 6 
as in (Table 7). Working of the machine is shown in Fig. 6 [57,58].
Apparatus designed by Wennergan (Fig. 7) [59]
Wennergan and his team of scientists have designed a modern 
dissolution apparatus having one to six chambers with novel simulation 
of chewing mastication phenomena. The comparative analysis of both 
apparatus is shown in (Table 6).
FACTORS AFFECTING RELEASE OF ACTIVE INGREDIENT
Nature of API and gums
Studies must be done on following virtues of API candidates like 
saliva solubility, pH-independent solubility and nature of drugs either 
hydrophobic or hydrophilic. API candidates, those are soluble in saliva 
release immediately whereas hydrophobic candidates will release from 
gum base material at a slower rate than this. Hydrophilic drug candidates 
release to the extent of 60-70% in first 10-15 minutes and rest of drug 
remaining in next 15-20 minutes [55]. Poor water-soluble cyclodextrin 
and other solubility enhancers or hydrotropic agents can be used. Gums 
which are hard in nature delay the release that overcomes by adding some 
excipients such as emulsifiers and softeners or both while formulation. 
Ion exchange resins and microencapsulation techniques can be used to 
produce controlled or sustained drug delivery systems [48,49].
Contact time
The therapeutic effects on local as well as the systemic side of physiology 
are dependent on the contact time span of the gum in the buccal cavity. 
For the optimum effect, it should be in the touch with the site at least for 
30 minutes where it is chewed about 60 times/minute.
Chewing intensity
Cycle per minute or chewing per minute is known as chewing frequency 
or chewing intensity. It has a vast effect on drug release and it changes 
Table 6: Comparison of in vitro dissolution apparatus
Single cell chamber Six chambered chewing cell
Batch size: 1 sample at a time Batch size: 6 samples simultaneously
Two pistons on each side (Teeth or jaw) Two horizontal pistons (Jaw) and a vertical piston (Tongue)
Brim of the lower surface is angled upward (Cavity) 45 degrees to 
prevent sliding of gum
A plunger rotates (Mastication) at the rate of 10-40 rpm* while piston is in 
motion
Movement in one cycle: Piston move toward each other Upward	and	one	downward	stroke	simultaneously
Compression between pistons Compression and rotation
Chewing rate is usually set at 60 per minute Chewing rate: 7.5-30/minute
Temperature-controlled reservoir Temperature-controlled reservoir
Dissolution media 20 ml Dissolution media 20 ml*
pH*: 6-7 pH: 6-7
Temperature: 37°C±5 Temperature: 37°±5
It is less used now days than the six-chambered apparatus Merits:
Faster rate and more reproducible
Only commercially available instrument
Gum is fixed while mastication goes on
*pH: Power of hydrogen; ml: Milliliter, rpm: Revolution per minute











*pH adjustment by Sodium Hydroxide or Hydrochloric acid, g/l: Gram per liter, 
KH2PO4: Monobasic potassium phosphate, Na2HPO4: Dibasic sodium phosphate, 
KHCO3: Potassium bicarbonate, KSCN: Potassium thiocynate, 
NaCl: Sodium chloride, KCl: Potassium chloride, MgCl2: Magnesium chloride, 
CaCl2: Calcium chloride
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from person to person. The speed of chewing also has its own effect. As 
per standard book like European Pharmacopoeia, 60 cycles per minute 
is optimum for a good release [61].
Compositional factors
Nature of gum base added ingredients and the respective proportion 
of both of them has a marked effect on the release. Hydrophilic nature 
of gum bases will release the API fastly, but hydrophobic bases show 
delayed release. If the gum base required is added more than the 
optimum, it will diminish the release up to half of the optimum [62,63].
THERAPEUTIC APPLICATIONS OF CHEWING GUMS
Local therapy
Oral diseases are the bull’s eye that has to be hit. Chewing gum can 
release therapeutic ingredients at a controlled rate over a length of 
time. This effect results in producing a prolonged effect. Sugar-free 
chewing gums are beneficial. Postprandial intake of this gum can 
elevate the buccal pH which decreases the chances of dental caries. 
Therefore, if the aim is to prevent dental caries, sugar-free chewing 
gums are recommended after meals as a substitute for brushing 
effect [29]. Fluoride-deficient areas have high chances of dental caries. 
A comparative study of fluoride containing and placebo chewing gums 
reveal that medicated gum remineralises and heal the enamel faster 
than non-functional gums [64,65]. Oral bacterial of fungal infections 
such as gingivitis, periodontitis, and others can be treated well by using 
buccal gums of chlorhexidine. Other benefits like reduction of plaque 
growth and tooth decay [66-68]. Xylitol or birch sugar containing 
chewing gums are recommended to use in malodor, dental plaque, 
enamel demineralization, and dental caries [69]. Calcium phosphate 
is also well used marketed formulation of therapeutic gums for dental 
caries treatment. Probiotics chewing gums have some beneficial 
effect on oral [70]. The results indicate that the probiotic gum may 
affect bacteria that produce malodorous compounds. It can assess by 
organoleptic score decrement actually compared with placebo [71]. An 
experimental study claimed that consumption of regular Happydent 
by subject or Xylitol can significantly decrease Mutans streptococci 
in saliva as well as it also shown detrimental effect on fatality of 
mother offspring streptococci transmission [72,73]. Clinical trials 
and experimental study reveal out that patients having candidiasis, 
Miconazole and their nitrates containing gums are similarly efficient 
like oral gel formulation, along with its wide acceptability by patient 
and better release [74,75]. Ascorbic acid intake alone or combination 
with carbamide in the form of chewing gums is found to decrease 
oral calculus as per research experiments [76]. Herbal medicines 
like eucalyptus and green tea extracts are also effective in dental and 
buccal problems like gingivitis. In one of the clinical trials, eucalyptus 
extract in chewing gums have shown a significant effect on periodontal 
health. The parameters such as gingival index, plaque accumulation, 
bleeding on probing and periodontal probing depth were statistically 
reduced [77]. Chewing gums have widespread use in oral health and 
many more to find in future research.
Systemic therapy
Adopting chewing gums as a delivery system, the systemic delivery of 
drugs which majorly absorbed from buccal mucosa are also benefitted. 
If we look from patient side, a list of benefits like rapid and local 
treatment, level of convenience, zero water for swallowing, no place 
and time restrictions and lesser gastrointestinal tract (GIT) side effects 
but strictly adhered with adults. Therapeutic applications of chewing 
gums in various physiological indications are.
Pain
Faster analgesic effect is the prime motive of analgesic drugs like in 
case of, headaches, migraine muscular spasm cold and cough, etc. These 
conditions require quick absorption of API. Hence, the aim satisfied 
by using transbuccal drug delivery system of chewing gums [78]. 
This formulation can also be used in case of severe algesia likewise 
in experimental study Methadone chewing gum has about equal 
bioavailability to the tablet formulation. Drug abusing problems with 
this study have almost reduced because the active substance can only 
be released after chewing [79].
Smoking habits
Since it is known that smoking is an oral, bad and injurious habit for 
health. To get rid of this, the only possible way is substituting this by 
any harmless oral habit like chewing. Formulations having Nicotine and 
Lobeline are found very successful in abandoning smoking [80-82].
Obesity
Lifestyle-related disease or ailments are on high verge today, in this 
queue obesity comes at first rank. Chewing of anorectic or fat dissolving 
substances	 is	 in	 need	 today	 [83].	 In	 US	 2013,	 a	 new	 “Dietburst”	
formulation which decreases your diet had launched by Arco Health 
Ltd. It contains a protein named Slendesta, a natural proteinase kinase 
inhibitor. Formulations having Guarana, Caffeine and chromium salts can 
be used and under trail for this purpose. They belong to central nervous 
system stimulating category but have side effects like stimulating 
lipolysis, thermogenic, and reduce appetite which ultimately ends with 
weight loss. Chromium picolinate can improve glycemic index of blood, 
so it can reduce instant craving for carbohydrates [84,85].
Postoperative benefits in bowel return
In a case study, based on clinical trial shows that patient undergoes 
major surgeries which make them bedridden, the patient loses the 
speed and normal rhythm of bowel evacuation like in the case of 
surgical correction of scoliosis. As the per the case study results 
chewing gums can reduce the time but not differ significantly. Chewing 
gums decreased the time period only by few hours but still a hope 
that chewing post surgery can facilitate the early return of bowel than 
control who are not taking these gums [86].
Motion sickness
Dimenhydrinate salt is the first drug comes into mind for motion 
sickness. It is in the market already in chewing gum dosage form. It gets 
absorbed easily from your buccal mucosa and directly goes to your blood 
stream [87]. According to a health report chewing increases release of 
digestive juices better digestion, increases the flow of saliva so acting 
as an antacid and prevents acid reflux ultimately relieves symptoms of 
motion sickness. Hopeful candidate drugs in future treatment by using 
gums are Scopolamine, Metoclopramide, and Ondansetron [29,88].
Table 8: Marketed products an active content
Product Drug/contents Indications
Aspergum Aspirin Analgesic
Nicorette, nicotinell Nicotine Smoking cessation 
Harbitrol (GSK)* Nicotine and resins Smoking cessation




Chlorhexidine Antibacterial, gingivitis 
and dental caries
Stay alert Caffeine Lipolytic, thermogenic, 
anti appetite
Go gum Guaran Lipolytic, thermogenic, 
antiapetite
Chooz Calcium carbonate Gatric acidity
Travvel Dimenhydrinate Motion sickness
Vitaminize, 
essentials
A, C, D, E, B, folic 
acid
Energy and dietary 
supplement
Stamil Vitamin C General health and diet
Happydent/orbit Calcium phosphate Tooth glittering and 
freshening
V-6 strength for 
teeth
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Sialogogic activity
In the condition of dry mouth or xerostomia chewing, gum mastication 
is the best exercise for stimulation of saliva in the mouth. Therefore, 
several trials, papers, and reviews have substantiated that gum chewing 
can relieve in these diseases [89]. Cholinergic drugs and several sugar 
alcohols can be used as sialogogic. Xerostomia is a condition that can be 
caused by intake of anticholinergics, antimuscarinic, antihypertensive, 
antianxiety, antidepressant, antiparkinsons, non-steroidal anti-
inflammatory drugs and condition such as Sjogren’s syndrome, 
glandular problems, and radio treatments [62,66,71].
Hypocalcemia
Several chewing gum formulations containing calcium are available 
on the market. Adolescents constitute a potential target group for a 
calcium chewing gum, as the calcium intake of young people is often 
very low. Calcium chewing gum with a pleasant taste is an attractive and 
convenient alternative to tablets [90].
Hypertension and angina pectoris
It is the most common CVS diseases which require constant watching. 
Most promising K+ channel openers considered for this is Nicorandil, a 
potent coronary vasodilator [1]. Current studies are going to develop 
and evaluate Nicorandil chewing gum as an antihypertensive and 
antianginal. The aim is to avoiding first pass metabolism and getting the 
rapid onset of action, reduce the dose potency to minimize side effects 
old age acceptance [91].
Male enhancement chewing gums
Modern days researchers have brought some extraordinary aspects 
of therapeutic gums. According to review, “M/S Future Lifestyles LLC, 
Florida” launched a chewing gum product having an effect on male 
enhancement. It can be used to increases libido, stamina, and blood 
flow that ultimately end into size increment lengthening and more 
powerful erections. The major contents of the chewing gums are 
some aphrodisiac herbs such as Pausinystalia yohimbe, Turnera diffusa 
Damiana, Lepidium meyenii, Panax ginseng and its varieties. It also 
includes Orchic powder extract from an animal source, some essential 
components, and excipients [92].
Multivitamin chewing gums
Vitamins are very valuable for diet and advances to have been made to 
provide them in or as a modern and innovative form. Chewing gums 
can also use as a popular buccal delivery vehicle for multiple vitamins. 
Vitamins are quickly absorbed by chewing because they immediately 
enter the bloodstream through the mucous membranes in the mouth 
and are thus optimally utilized [93]. It helps in provide essential dietary 
vitamins such as A, C, D, E, B1, B2, B3, B5, B6, B12, folic acid, and biotin. 
It also serves s as breath freshener supported by menthol, spearmint or 
cinnamon [94].
MARKETED PRODUCTS AND BRANDS OF THERAPEUTIC GUMS
There are several worldwide products acceptable as chewing gums 
containing medicinally active substances for different local as well as 
systemic action also known as functional gums. Some of them are given 
in Table 8 [95].
GUMS AS FASHION IN LIFESTYLE
Mainly non-medicated gums that are chewed regularly just a trend 
point of view in youngster lifestyle especially in western countries have 
some serious and long-term side effects on physiology. According to 
article by chewing or gums as an addiction has following side effects 
listed below.
Demotivate healthy eating habits and appetite
Chewing reduces the food cravings which logically help to avoid eating 
unhealthy foods but it also is known by literature that it diminish 
appetite and push to eat less nutritious food than those of non-gum-
chewers. They were less likely to eat fruits and vegetable, because of 
that inherent minty flavors which make them taste bitter.
Muscular disorder in jaw
It’s regular use, especially from one side of buccal cavity imbalances the 
jaw muscle. A person is only using certain set of muscle for a long time 
which ends up into arthralgia, headaches, dental pain and pain in the 
ear. Teenagers are notorious for gum chewing and popping; they are the 
major affected segment of the population.
GIT problems
It can cause an intake of excess air which results in abdominal pain, 
swollen belly. Pseudo signals of food intake generated which stimulate 
waste secretion of enzymes and acids, but nothing to digest actually. 
High ingestion of polyols like Xylitol or Sorbitol as a major ingredient in 
therapeutic gums can cause laxative effects [96].
Dental erosion
It is actually a process of incremental decalcification. Sugar-containing 
therapeutic gums is the most harmful thing for teeth whereas sugar-
free gums are less likely to deteriorate the teeth. They also have some 
mild ill effects because of their acidic flavorings and preservatives.
Problems due to artificial sweeteners
As we know that transbuccal means dosage form which is directly 
contacted with oral mucosa as well as systemic circulation, therefore it 
also increases the chances of penetration of such toxic or carcinogenic 
excipients into the blood stream. Saccharin, cyclamates, and aspartames 
are among them. Sweeteners are unavoidable in the buccal dosage form 
as a fact. Aspartame biotransformed into formaldehyde and methyl 
alcohol which are carcinogen and position for body, respectively. It also 
produces some signs of headaches. Sucralose is the other one which 
shows signs of anemia, infertility, abortions in some animal studies.
Problems due to some other dangerous excipients
Listed below some of the chewing gums additives that must be avoided 





Interferes the root canal therapy and dental fillings [97,98]
Chewing gum regular basis can have drastic and ill effects on patient 
who had undergone root canal or rental filling like therapy. It leaches 
out the mercury amalgam or the filling from dental cavity into your body. 
It has some late shown effects like oxidative stress on tissues [97,98].
CONCLUSIONS AND FUTURE PROSPECTS
Novel things discovered or introduced should always acceptable, 
admissible and affordable and adequately effective for the common 
one. Previously, chewing gum was mainly considered a confectionery 
product; however, fluoride chewing gum, and especially nicotine 
chewing gum which was launched in the 1970s, enlighten the way for 
a more general acceptance of chewing gum as a drug delivery system. 
Therapeutic gums are actually a modified release systems adhering to 
the most convenient and compliant way of drug dosing. The inclusion 
of medical chewing gum in the European Pharmacopoeia (under 
medicated chewing gum) in 1998 has further contributed to full 
acceptance worldwide. Medical chewing gum meets the high-quality 
standards of the pharmaceutical industry and can be formulated to 
obtain different release profiles of active substances, thus enabling 
distinct patient group targeting. A few decades ago, the only treatment 
for some diseases was surgical procedures (e.g., gastric ulcers); 
however, today more and more diseases are treated by medication. This 
trend is likely to continue as sophisticated research methods allow the 
development of medication for an increasing number of diseases. At the 
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same time, there is a demand for efficient and convenient drug delivery 
systems. In general, it takes time for a new drug delivery system to 
establish itself on the market and gain acceptance by both professionals 
and patients. Health encloses in gum suitable attract the patient and 
provide added value to the customer as well as differentiating market 
trend set. Medicated chewing gum is a valid alternative to standard, 
chewable or orally disintegrating tablet presentations. Now, these 
therapeutic gums are intervening into sex enchantments, erectile 
dysfunction and oral contraceptives category as for those who hate 
swallowing the drugs. There are also some scopes for chewing gum for 
research in the treatment of amnesia, Alzheimer and memory defects. 
No solid evidence is available that chewing gums increases aspects 
of mental performance, but there are some experiments and running 
clinical trials that shows practicing gum can improve episodic memory, 
working memory, and mood and also act as stress relief. Some trials 
also show that chewing action (gum) also helps in attaining the normal 
bowel evacuation and early intestinal stimulation after cesarean 
section in women. There is a lot of scopes to produce therapeutic gums 
containing memory enhancing herbs, anxiolytics and drugs acting on 
the recovery of normal bowel evacuation for future research. Chewing 
gums as we discussed are very potential in targeting oral diseases 
and disorders presently as well as a marvelous futuristic approach for 
aiming the systemic ailments.
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